As of 2025-11-17, the Relative Valuation of Basilea Pharmaceutica AG (BSLN.SW) is 60.32 CHF. This relative valuation is based on P/E multiples. With the latest stock price at 46.85 CHF, the upside of Basilea Pharmaceutica AG based on Relative Valuation is 28.7%.
The range of the Relative Valuation is 55.30 - 66.55 CHF.
| Range | Selected | |
| Trailing P/E multiples | 11.0x - 12.2x | 11.6x |
| Forward P/E multiples | 11.3x - 12.1x | 11.7x |
| Fair Price | 55.30 - 66.55 | 60.32 |
| Upside | 18.0% - 42.0% | 28.7% |
| Date | P/E |
| 2025-11-14 | 8.59 |
| 2025-11-13 | 8.68 |
| 2025-11-12 | 8.60 |
| 2025-11-11 | 8.45 |
| 2025-11-10 | 8.31 |
| 2025-11-07 | 8.23 |
| 2025-11-06 | 8.26 |
| 2025-11-05 | 8.35 |
| 2025-11-04 | 8.55 |
| 2025-11-03 | 8.30 |
| 2025-10-31 | 8.52 |
| 2025-10-30 | 8.48 |
| 2025-10-29 | 8.45 |
| 2025-10-28 | 8.57 |
| 2025-10-27 | 8.59 |
| 2025-10-24 | 8.79 |
| 2025-10-23 | 8.94 |
| 2025-10-22 | 8.90 |
| 2025-10-21 | 8.92 |
| 2025-10-20 | 8.91 |
| 2025-10-17 | 8.83 |
| 2025-10-16 | 8.96 |
| 2025-10-15 | 8.84 |
| 2025-10-14 | 8.91 |
| 2025-10-13 | 8.94 |
| 2025-10-10 | 9.00 |
| 2025-10-09 | 9.17 |
| 2025-10-08 | 9.26 |
| 2025-10-07 | 9.31 |
| 2025-10-06 | 8.95 |
| 2025-10-03 | 8.93 |
| 2025-10-02 | 8.84 |
| 2025-10-01 | 8.75 |
| 2025-09-30 | 8.67 |
| 2025-09-29 | 8.46 |
| 2025-09-26 | 8.29 |
| 2025-09-25 | 8.44 |
| 2025-09-24 | 8.48 |
| 2025-09-23 | 8.56 |
| 2025-09-22 | 8.61 |
| 2025-09-19 | 8.75 |
| 2025-09-18 | 8.37 |
| 2025-09-17 | 8.44 |
| 2025-09-16 | 8.41 |
| 2025-09-15 | 8.33 |
| 2025-09-12 | 8.52 |
| 2025-09-11 | 8.42 |
| 2025-09-10 | 8.45 |
| 2025-09-09 | 8.49 |
| 2025-09-08 | 8.52 |